1. Home
  2. RGP vs ANIX Comparison

RGP vs ANIX Comparison

Compare RGP & ANIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Resources Connection Inc.

RGP

Resources Connection Inc.

HOLD

Current Price

$3.77

Market Cap

120.9M

ML Signal

HOLD

Logo Anixa Biosciences Inc.

ANIX

Anixa Biosciences Inc.

HOLD

Current Price

$2.85

Market Cap

104.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RGP
ANIX
Founded
1996
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
120.9M
104.0M
IPO Year
2000
2013

Fundamental Metrics

Financial Performance
Metric
RGP
ANIX
Price
$3.77
$2.85
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
3
Target Price
$7.00
$8.67
AVG Volume (30 Days)
337.8K
100.6K
Earning Date
04-08-2026
05-27-2026
Dividend Yield
7.43%
N/A
EPS Growth
N/A
12.82
EPS
N/A
N/A
Revenue
$551,331,000.00
$210,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$1.49
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.06
$2.44
52 Week High
$6.07
$5.46

Technical Indicators

Market Signals
Indicator
RGP
ANIX
Relative Strength Index (RSI) 54.25 54.99
Support Level $3.47 $2.74
Resistance Level $3.82 $3.10
Average True Range (ATR) 0.20 0.16
MACD 0.03 0.04
Stochastic Oscillator 89.45 91.11

Price Performance

Historical Comparison
RGP
ANIX

About RGP Resources Connection Inc.

Resources Connection Inc provides consulting and business initiative support services predominantly through its operative subsidiary, Resources Global Professionals. It has two segments RGP ( Resources Global Professionals.) and Sitrick. The RGP segment is focused on delivering consulting services catering to its client's operational needs and change initiatives utilizing a combination of bench and on-demand, talent. The Sitrick segment provides corporate, financial, transactional, and crisis communication and management services. The company generates a majority of its revenue from the RGP segment. Geographically, it derives its key revenue from North America and the rest from Europe and the Asia Pacific region.

About ANIX Anixa Biosciences Inc.

Anixa Biosciences Inc a cancer-focused biotechnology company, develops vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.

Share on Social Networks: